对于IBD来说,新的治疗机会的景观
Andrés Hurtado-Lorenzo1, Jennifer L Swantek1
1Translational Research & IBD Ventures, Research Department, Crohn's & Colitis Foundation, New York, NY, United States.
新兴的炎症性肠病 (IBD) 疗法旨在恢复免疫平衡,肠道屏障功能和微生物群健康. 精准医学和向药物输送为那些对当前治疗没有反应的患者提供了新的希望.
科学领域:
- 胃肠道学和免疫学
- 翻译医学是一种翻译医学.
- 药物发现 药物发现 药物发现
背景情况:
- 炎症性肠病 (IBD) 存在重大管理挑战,许多患者经历疾病进展或对生物制剂等现有疗法缺乏反应.
- 目前的治疗方法往往无法预防不可逆转的并发症,这凸显了IBD护理的关键未满足需求.
- 超过一半的IBD患者面临疾病进展尽管干预措施,强调当前治疗策略的局限性.
研究的目的:
- 为炎症性肠道疾病 (IBD) 提供新和新兴治疗策略的概述.
- 探索解决免疫失调,肠道屏障缺陷,纤维化,,IBD中的微生物组失衡的创新方法.
- 突出精准医学和先进的药物输送系统在个性化IBD管理中的作用.
主要方法:
- 审查新兴的治疗点,包括细胞因子网络,白细胞贩运和新型免疫路径.
- 探索基于细胞的疗法,如调节性T细胞和介质干细胞 (MSC).
- 讨论肠道屏障恢复,纤维化逆转,微生物组调节 (例如便微生物群移植) 和向药物输送的策略.
主要成果:
- 新的方法专注于恢复免疫平衡,增强肠道屏障完整性,逆转纤维化和.
- 介酶干细胞 (MSC) 显示出治疗囊和促进愈合的潜力.
- 通过便微生物种移植和定义的细菌联盟恢复肠道微生物组平衡是关键的新兴战略.
结论:
- 针对免疫路径,屏障功能,微生物组和纤维化的新兴疗法为改善IBD管理提供了显著的潜力.
- 精准医学,利用多组学来发现生物标志物,对于开发个性化的IBD护理策略至关重要.
- 这些创新方法有望克服当前治疗方法的局限性,并改善IBD患者的治疗结果.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
